Resources

Brochures

IRP Fact Sheet

NIDC Product Catalog

Medical Isotopes Brochure

The DOE Isotope Program (2016)

Isotope Science and Production

Reports

Date	Title/Report
August 2008	Workshop on the Nation’s Need for Isotopes: Present and Future (PDF)
April 2009	Report to NSAC of the Subcommittee on Compelling Research Opportunities using Isotopes (PDF) Charge Letter (PDF)
August 2009	Report to NSAC of the Subcommittee on Isotopes for the Nation's Future: A Long Range Plan (PDF) Charge Letter (PDF)
July 2015	Meeting Isotope Needs and Capturing Opportunities For The Future (PDF) Charge Letter (PDF)
January 2023	Artificial Intelligence for Isotopes: Report on the 2022 Workshop on Artificial Intelligence for Isotope R&D and Production

Videos

Workshops

Highlights

View all Highlights

Images showing mice injected with radioactive antimony. Left panel with TREN-CAM shows how the radioactive antimony will be active longer in the treatment areas. The right panel shows that the antimony without TREN-CAM doesn’t stay in the desired areas.

Progress Towards Unlocking Antimony’s Cancer Treatment Potential

Researchers gain a new understanding of the binding chemistry of radioactive antimony, opening doors for targeted therapy.

Steps in terbium-161 (Tb-161) production. The University of Utah TRIGA reactor induces thermal neutron capture on gadolinium-160 (Gd-160), which decays to Tb-161. Separating the Gd-160 target yields high-purity Tb-161 for cancer therapy and diagnosis.

To Advance Cancer Therapy, University Starts Producing Terbium-161

A University of Utah research team demonstrates that a low power university research reactor can produce terbium-161 at high purity from gadolinium-160.

Contact

Address Office of Isotope R&D and Production, IRP
U.S. Department of Energy
1000 Independence Avenue, SW
Washington, D.C. 20585-1290

Phone Tel (301) 903-3400

Email Send us a message Isotopes@science.doe.gov

sub nav